PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia
· Delayed Price · Currency is IDR 525.00
-5.00 (-0.94%)
Last updated: Jun 16, 2025
IDX:OBAT Revenue
PT Brigit Biofarmaka Technologi Tbk had revenue of 29.01B IDR in the quarter ending March 31, 2025, with 54.01% growth. This brings the company's revenue in the last twelve months to 124.99B, up 73.71% year-over-year. In the year 2024, PT Brigit Biofarmaka Technologi Tbk had annual revenue of 120.63B with 111.89% growth.
Revenue (ttm)
124.99B
Revenue Growth
+73.71%
P/S Ratio
2.52
Revenue / Employee
5.21B
Employees
23
Market Cap
315.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120.63B | 63.70B | 111.89% |
| Dec 31, 2023 | 56.93B | 18.43B | 47.89% |
| Dec 31, 2022 | 38.50B | 642.48M | 1.70% |
| Dec 31, 2021 | 37.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition